Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|February 1, 1988
Ha-ras restriction fragment length polymorphisms in colorectal cancerF S Wyllie, V Wynford-Thomas, N R Lemoine, et al.
The New England Journal of Medicine|April 13, 1995
Transdermal nicotine as maintenance therapy for ulcerative colitisG A Thomas, J Rhodes, V Mani, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2000
Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitisJ T Green, C Richardson, R W Marshall, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 19, 1998
A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expressionN Scott, A Hale, M Deakin, et al.
Nucleic Acids Research|April 25, 1994
Antibodies generated from human immunoglobulin miniloci in transgenic miceS D Wagner, G T Williams, T Larson, et al.
Histopathology|August 1, 1993
Granulomatous hidradenitis suppurativa and cutaneous Crohn's diseaseR L Attanoos, M A Appleton, L E Hughes, et al.
European Journal of Gastroenterology & Hepatology|August 1, 1996
Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitisG A Thomas, J Rhodes, K Ragunath, et al.
The American Journal of Gastroenterology|September 11, 1998
Clinical status of ulcerative colitis in patients who smokeJ T Green, J Rhodes, K Ragunath, et al.
British Journal of Cancer|November 22, 2012
Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer and the predictive role of endoluminal ultrasonographyT D Reid, D S Y Chan, S A Roberts, et al.
Gut|September 1, 1991
Smoking, humoral immunity, and ulcerative colitisE D Srivastava, J R Barton, S O'Mahony, et al.
Pageof 21